1.
Bioorg Med Chem Lett
; 14(12): 3155-9, 2004 Jun 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15149665
RESUMO
A series of (5-(2H)-isoxazolonyl) ureas were developed as nanomolar inhibitors of hormone-sensitive lipase, an enzyme of potential importance in the treatment of diabetes.